Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 27Observational 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 2

Interventions

Blood Specimen Collection 22Surveys and Questionnaires 19Nivolumab 14Ipilimumab 12pembrolizumab 11Gene Expression Profiling 11Biopsy 10trametinib 9dabrafenib 8Flow Cytometry 8Specimen Handling 7Polymerase Chain Reaction 7Tomography, Optical Coherence 6Therapeutics 6Immunohistochemistry 6Imiquimod 6Amplified Fragment Length Polymorphism Analysis 6Watchful Waiting 5Psychiatric Rehabilitation 5Immunotherapy 5Data Collection 53-ingenyl angelate 5Mohs Surgery 4Microarray Analysis 4Interviews as Topic 4Immunoenzyme Techniques 4Drug Therapy 4Dermoscopy 4sonidegib 3encorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Interferon-alpha × Dermatologic × Clear all
NCT00897520 2017-05-19

Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy

Eastern Cooperative Oncology Group

Completed
40 enrolled
Dermatologic

Melanoma

NCT02074605 2014-02-28

Cognitive Effects of Interferon in Patients With Melanoma

University of Arizona

Completed
36 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡